\n\n\n\n\t\t\n\t\t\tTalima Therapeutics\n\t\t\thttp://www.talima.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tTalima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy we...More»
\n\t\t\tTalima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy we seek to present innovative solutions that overcome drug delivery barriers. As an early-stage start-up company, we put all our efforts into designing highly customized drug-delivery systems that optimize the therapeutic performance without the undesired side effects. We collaborate with partners who excel in their area of expertise and recognize the value we bring to drug-delivery development. Our innovations will have significant impact on improving human health and quality of life.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSan Carlos, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\ttalima,\n\t\t\t\tdelivery,\n\t\t\t\ttherapeutics,\n\t\t\t\tdrug,\n\t\t\t\tdrug delivery,\n\t\t\t\tbiopharmaceuticals\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $19M (05/29/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tDe Novo Ventures,\n\t\t\t\t\t\n\t\tLatterell Venture Partners,\n\t\t\t\t\t\n\t\tPalo Alto Investors,\n\t\t\t\t\t\n\t\tU.S. Venture Partners\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tMicroCHIPS Inc.\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tSelecta Biosciences,\n\t\t\t\t\tAclara BioSciences,\n\t\t\t\t\tMountain View Pharmaceuticals,\n\t\t\t\t\tBind Biosciences,\n\t\t\t\t\tVentiRx,\n\t\t\t\t\tExelixis,\n\t\t\t\t\tLentigen,\n\t\t\t\t\tZelos Therapeutics,\n\t\t\t\t\tMicroCHIPS Inc.,\n\t\t\t\t\tSynergia Pharma\n\t\t\t\t
\n\t\t\t